David W. Ghesquiere
Senior Vice President, Corporate & Business Development | NanoString Technologies
Mr. Ghesquiere joins NanoString with over 20 years of experience in the biopharmaceutical industry in both North America and Europe. Mr. Ghesquiere was most recently Senior Vice President, Corporate & Business Development at Dendreon Corporation, where his primary responsibility was leading the strategic process to identify and pursue next generation technologies and therapeutics. Previously, he was an executive at OSI Pharmaceuticals (acquired by Astellas) where from 2005 to 2010 he held positions of increasing responsibility including Senior Vice-President of Corporate & Business Development, and served as a Board Member and Managing Director & Secretary of OSI Investment Holdings GmbH / OSI Investment Management GmbH. Earlier in his career, Mr. Ghesquiere was Director of Global Business Development for Aventis Pharmaceuticals (acquired by Sanofi) and worked in product marketing at Johnson & Johnson.